It is best to obtain professional advice from your doctor before using Valupak Vitamin D 3 is you are pregnant, trying to become pregnant, or breastfeeding.

Restricted for the dietary management of patients with cystic fibrosis on the specific recommendation of a specialist in cystic fibrosis. Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data. Colecalciferol 1000 IU Capsules should be prescribed with caution to patients suffering from sarcoidosis because of the risk of increased metabolism of vitamin D to its active form. These patients should be monitored with regard to the calcium content in serum and urine.Colecalciferol and its metabolites are excreted in breast milk. Overdose in infants induced by nursing mothers has not been observed but allowance for any maternal dose should be made when prescribing vitamin D products to a breast-fed child. The cytotoxic agent actinomycin and imidazole antifungal agents interfere with vitamin D activity by inhibiting the conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D by the kidney enzyme, 25-hydroxyvitamin D-1-hydroxylase. Liquid : Fultium-D3 ® Drops 2740 units/ml. 25ml bottle. 12 drops contain 800 units. Pro D3 ® 2000 units/ ml drops may be supplied as an alternative to Fultium D3 ® drops during supply problems

Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised. Rehydration and the treatment with diuretics e.g. furosemide to ensure adequate diuresis should be considered. Additional treatment with calcitonin or corticosteroids can also be considered. Certain populations are at high risk of vitamin D deficiency, and may require higher doses and monitoring of serum 25(OH)D: Colecalciferol 1000 IU Capsules should be used with caution in patients with impairment of renal function and the effect on calcium and phosphate levels should be monitored. The risk of soft tissue calcification should be taken into account. In patients with severe renal insufficiency, vitamin D in the form of Colecalciferol is not metabolised normally and other forms of vitamin D should be used.

Symptoms & Causes of Vitamin D Deficiency

The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC. Suspension 500mg of dl-alpha-tocopherol acetate (500 units) in 5ml.(See tableof liquid medicines requiring dose adjustment) If Colecalciferol is combined with metabolites or analogues of vitamin D careful monitoring of serum calcium levels is recommended. Tablets disperse in water if needed. See here for general advice on dispersing tablets. Liquid can be made specially if required - SFH: send patients to KMH pharmacy for supplies While Valupak Vitamin D 3 is unlikely to cause side effects, some people may experience side effects.